Subscribe To Our Free Newsletter |
Aurobindo Pharma gets 2nd US FDA nod in September
USFDA has approved Aurobindo Pharma’s Caffeine citrate, which is used in treatment of apnea of prematurity (lack of breathing in premature infants).